Use of mifepristone for the treatment of amyotrophic lateral sclerosis
AssigneeCorcept Therapeutics, Inc.
InventorJoseph K. Belanoff
Life of this patent
Estimating the term…
Abstract
The invention generally pertains to the discovery that agents capable of inhibiting the binding of cortisol to its receptor can be used in methods for treating patients diagnosed with Amyotrophic Lateral Sclerosis (ALS).
Claims20
A method for ameliorating the symptoms and/or slowing the rate of disease progression in a patient diagnosed with amyotrophic lateral sclerosis (ALS), the method comprising administering a therapeutically effective amount of a glucocorticoid receptor specific antagonist (GRA) to a subject in need thereof, with the proviso that the subject not be otherwise in need of treatment with a glucocorticoid receptor antagonist.
Dependencies are inferred from the claim text.